Dr. Tram Nguyen specializes in quantitative economic analysis and modeling within the context of labor and employment discrimination matters, industrial organization, and firm management. She has extensive experience analyzing large and varied datasets, as well as expertise in machine learning and statistical tools.
Dr. Nguyen has provided support to clients on issues related to the economics of class certification for both direct and indirect purchaser classes and applying rigorous econometric analyses in estimating antitrust damages in dozens of matters. Her casework spans a broad range of industries, including agricultural products, railroads, chemicals, pharmaceuticals, and consumer products. Across these fields, Dr. Nguyen has extensive experience in leading teams of consultants to conduct empirical analysis of economic issues and present analytical insights in expert reports.
Dr. Nguyen’s academic research focused on issues of labor and employment in developing countries. In her dissertation, Dr. Nguyen analyzes the effects of a sector-specific minimum wage on wages in other sectors by examining the garment industry in Cambodia. During her undergraduate and graduate studies, she was awarded several research grants, excellent teaching recognitions, and academic prizes.
- Research Assistant, Federal Reserve Bank of Boston
Insights & News
- Published Article, Law360 | 05.16.2022
In this article, Dr. George Korenko and Dr. Tram Nguyen identify dimensions along which, over aggregation and averaging, likely lead to findings of uninjured class members.
- Published Article, Law360 | 07.21.2020
In this article, published in Law360, Edgeworth Partner Dr. George Korenko and Principal Consultant Dr. Tram Nguyen discuss three key issues cited in the Court of Appeals opinion and their implications for the economic analysis of predominance in the Lamictal case and in other pay-for-delay litigations.
- Blog, 09.06.2022
When pharmaceutical manufacturers develop a new branded drug to take to market, they are granted a period of exclusivity via patent to help recoup the massive costs of research and development. Upon expiration of this patent, generic manufacturers can enter the market with therapeutically equivalent products and compete with the brand.
- Blog, 02.01.2022
Economic experts often employ two approaches that use public settlement information to estimate potential exposure for a client- a top-down approach or a bottom-up approach.
- Navigating Antitrust Issues in the Pharmaceutical and Life Science Industries: Key Trends and Challenges ExploredEvent, 06.21.2022
A panel of distinguished thought leaders, including Edgeworth Principal Tram Nguyen, provide the audience with an in-depth discussion of the trends, developments, and critical issues surrounding pharmaceutical antitrust matters.
- Event, Antitrust Economics Workshop | Fordham Competition Law Institute | 10.07.2020
Edgeworth Economics will host the Antitrust Economics Workshop, to be held in advance of the 47th Annual Conference on International Antitrust Law
- Consumer Goods